Project Details
| Short title | A novel gamma delta T cell platform technology to enable drug-tunable targeting of CAR tumour associated antigen targets |
|---|---|
| Status | Finished |
| Effective start/end date | 3/04/17 → 2/10/19 |
Funding
- The Wellcome Trust
A novel gamma delta T cell platform technology to enable drug-tunable targeting of CAR tumour associated antigen targets
- Lee, Steve (Co-Investigator)
- Willcox, Benjamin (Principal Investigator)